The financing comes on top of the company's $900 million annual research and development investment in the U.S.

Add MobiHealthNews to your network.

The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combatting the FDA’s claim that it qualifies as a regulated medical device.

Kenrick Cato, nurse scientist, pediatric data and analytics, Children's Hospital of Philadelphia, says that nurses are ...